‘Neuralink does not get permission to test with chips in brains’

Neuralink has not received FDA approval for human trials of brain implants. The Elon Musk company wants to use a chip to ensure that people with disabilities can type.

The FDA rejected the application last year, reports Reuters. The authority issued a list of objections to the content of the human trials, seven sources told the news agency. Since that time, Neuralink has been trying to remove those objections, but has not yet succeeded. If those objections are resolved, the tests could still start.

Neuralink has not publicly commented on the FDA’s objections. Musk said late last year that “most of the paperwork” had been done, but then said nothing about the rejected application. Permission is required before the company can conduct human trials.

Neuralink wants to develop a brain-computer interface. The first goal is to enable paralyzed people to do more by letting them operate a computer. Neuralink was founded in 2016, but the company will not announce its plans until 2019.